Globavir Company

Globavir was founded in 2011 by Dr. Shalabh Gupta. Globavir was built on multiple licenses from Stanford University from multiple different professors and multiple different departments. In 2014, Globavir acquired BioCycive in all stock deal, and BioCycive became a wholly owned subsidiary of Globavir. In 2015, BioCycive's lead program was partnered with Sorrento Therapeutics. In 2016, Globavir partnered its diagnostic test with Bio-Rad.
Technology: Biotechnology, Health Care, Health Diagnostics, Therapeutics
Industry: Drug Repurposing
Headquarters: Los Altos, California, United States
Founded Date: 2013-07-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 2
Total Funding: 11500000
Estimated Revenue: Less than $1M
Last Funding Date: 2018-05-01
Last Funding Type: Series B

Visit Website
info@globavir.com
https://twitter.com/Globavir
Register and Claim Ownership